Clinical Trial Update: Treat-to-target Prednisolon Taper in Patients With Polymyalgia Rheumatica [NA]

View source ↗

Summary

This clinical trial is evaluating a treat-to-target prednisolone taper strategy in polymyalgia rheumatica; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polymyalgia Rheumatica

Drugs mentioned

• Prednisolone (Prednisolone)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Polymyalgia Rheumatica | NA | Status: ACTIVE_NOT_RECRUITING